Literature DB >> 15056595

Diabetes mellitus and schizophrenia: historical perspective.

Dora Kohen1.   

Abstract

BACKGROUND: Although recent research has focused on the possible role of antipsychotic medications in the development of diabetes mellitus, studies conducted in the pre-neuroleptic era suggest that schizophrenia itself might predispose individuals to diabetes. AIMS: To test the hypothesis that diabetes mellitus is an integral part of schizophrenia.
METHOD: Historical literature review.
RESULTS: Many people with severe mental illnesses, including dementia praecox, showed abnormal responses to insulin and diabetes-like glucose tolerance curves long before the advent of phenothiazines. Early studies with chlorpromazine suggested that a latent tendency towards diabetes in patients with schizophrenia could be unmasked by this treatment.
CONCLUSIONS: Diabetes and disturbed carbohydrate metabolism may be an integral part of schizophrenia. Further research is required to explain how metabolic factors, medications and lifestyle factors might precipitate diabetes in patients with this mental disorder.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15056595     DOI: 10.1192/bjp.184.47.s64

Source DB:  PubMed          Journal:  Br J Psychiatry Suppl        ISSN: 0960-5371


  39 in total

1.  Physical Health and Dual Diagnosis.

Authors:  Debbie Robson; Sarah Keen; Pia Mauro
Journal:  Adv Dual Diagn       Date:  2008

2.  Metabolic syndrome in antipsychotic naive African patients with severe mental illness in usual care.

Authors:  Shamima Saloojee; Jonathan K Burns; Ayesha A Motala
Journal:  Early Interv Psychiatry       Date:  2017-04-12       Impact factor: 2.732

3.  Schizophrenia as a systemic disease.

Authors:  Brian Kirkpatrick
Journal:  Schizophr Bull       Date:  2009-02-04       Impact factor: 9.306

Review 4.  Medication errors in psychiatry: a comprehensive review.

Authors:  Ric M Procyshyn; Alasdair M Barr; Tracey Brickell; William G Honer
Journal:  CNS Drugs       Date:  2010-07       Impact factor: 5.749

Review 5.  Atypical antipsychotics and diabetic ketoacidosis: a review.

Authors:  Melanie D Guenette; Margaret Hahn; Tony A Cohn; Celine Teo; Gary J Remington
Journal:  Psychopharmacology (Berl)       Date:  2013-01-24       Impact factor: 4.530

6.  Physical Functional Limitations in a First-Admission Cohort at Midlife: Findings From the Suffolk County Mental Health Project.

Authors:  Sean A P Clouston; Katherine Jonas; Laura J Fochtmann; Evelyn J Bromet; Roman Kotov
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-06-18       Impact factor: 6.053

Review 7.  Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.

Authors:  Alex J Mitchell; Davy Vancampfort; Kim Sweers; Ruud van Winkel; Weiping Yu; Marc De Hert
Journal:  Schizophr Bull       Date:  2011-12-29       Impact factor: 9.306

8.  Metabolic syndrome in people with schizophrenia: a review.

Authors:  Marc DE Hert; Vincent Schreurs; Davy Vancampfort; Ruud VAN Winkel
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

9.  The risk of diabetes in deficit schizophrenia.

Authors:  William R Keller; Carol Vidal; Eric S Park; Gregory P Strauss; Bernard A Fischer
Journal:  Clin Schizophr Relat Psychoses       Date:  2014-01

10.  A UK audit of screening for the metabolic side effects of antipsychotics in community patients.

Authors:  Thomas R E Barnes; Carol Paton; Mary-Rose Cavanagh; Elizabeth Hancock; David M Taylor
Journal:  Schizophr Bull       Date:  2007-05-04       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.